Skip to main content
. 2017 May 2;9(1):137–145. doi: 10.1111/jdi.12659

Figure 1.

Figure 1

Patient disposition. αGI, α‐glucosidase inhibitor; BG, biguanide; DPP‐4, dipeptidyl peptidase‐4; HbA1c, glycated hemoglobin; OHA‐Q, Oral Hypoglycemic Agent Questionnaire; SU, sulfonylurea.